期刊文献+

吉西他滨联合卡铂治疗老年非小细胞肺癌临床观察

下载PDF
导出
摘要 目的 :观察吉西他滨加卡铂治疗老年非小细胞肺癌的疗效和毒副作用。方法 :对 3 2例不能手术或手术治疗后复发转移的老年非小细胞肺癌患者 ,接受GC方案 (吉西他滨加卡铂 )化疗 2周期后评价疗效。结果 :总有效率 43 7% (14 3 2 ) ,其中 ,初治患者有效率 5 0 % (10 2 0 ) ,复治患者有效率为 3 3 3 % (4 12 )。主要毒性反应为骨髓抑制 ,经对症处理均可恢复。结论 :GC方案在治疗老年非小细胞肺癌中疗效好 ,毒副反应轻。
机构地区 山西省肿瘤医院
出处 《山西职工医学院学报》 CAS 2004年第4期31-32,共2页 Journal of Shanxi Medical College for Continuing Education
  • 相关文献

参考文献6

二级参考文献10

  • 1Mok TS Zee B Chan AT et al.A phase Ⅱ study of gemcitabine plus oral etoposide in the treatment of patients with advanced non-small cell lung carcinoma [J].Cancer,2000,89(3):543-550.
  • 2[1]Antonuzzo A, Gall L, Ricci S, et al. Gemcitabine monotherapy in the eldery patients with advanced NSCLC. Ann Oncol,1998,9(Suppl 4)∶A428P.
  • 3[2]Pasquini E, Tassinari D, Nicolini M, et al. Gemcitabine in advanced NSCLC of elderly, A Phase Ⅱ study. Ann Oncol,1998(Suppl 4)∶A154.
  • 4[3]Grilli R, Oxman AD, Julian JA. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? J Clin Oncol,1993,11(10)∶1866-1872.
  • 5[4]Non-small-cell lung cancer Collaborative Group:Chemotherapy in non-small-cell lung cancer: A meta-analysis using update on individual patients from 52 randomized Chemical trials. BMJ,1995,311(10)∶899-909.
  • 6[5]Balducci L, Extermann M. Cancer and aging. An evolving panorama. Hematol Oncol Clin North Am,2000,14(1)∶1-16.
  • 7[6]Crino L, Scagliotti G, Marangolo M, et al. Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase Ⅱ study. J Clin Oncol,1997,15(1)∶297-303.
  • 8[7]Soto parra HJ, Gavina R, Antoneli G, et al. Superiority of 3-weeks VS 4-weeks scheduce of cisplatin and gemcitabine. Prot ASCO,2000,19∶546a
  • 9[8]Carrato A, Carciao Comez J, Alberola V, et al. CARBO in combination with gemcitabine in advanced NSCLC. Proc ASCO,1999,18∶A1936.
  • 10李以欣.癌症化学治疗的首选药物[J].国外医药(合成药.生化药.制剂分册),1998,19(2):89-96. 被引量:18

共引文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部